DICE Therapeutics, Inc. (DICE) Tops Q1 EPS by 6c

DICE Therapeutics, Inc. (NASDAQ: DICE) reported Q1 EPS of ($0.54), $0.06 better than the analyst estimate of ($0.60).

For earnings history and earnings-related data on DICE Therapeutics, Inc. (DICE) click here.

You May Also Be Interested In

• Tesla to launch Cybercab in Austin this month - report
• Fabrinet (FN) Tops Q4 EPS by 29c, Beats on Revenue; Offers Guidance
• Royal Unibrew reports higher interim first-half profit as margins improve